المؤلفون: Motawea, Karam R., Gaber, Hamed, Singh, Ravi B., Swed, Sarya, Elshenawy, Salem, Talat, Nesreen Elsayed, Elgabrty, Nawal, Shoib, Sheikh, Wahsh, Engy A., Chébl, Pensée, Reyad, Sarraa M., Rozan, Samah S., Aiash, Hani

المصدر: Clinical Cardiology ; volume 45, issue 10, page 1011-1028 ; ISSN 0160-9289 1932-8737

الوصف: Aim This meta‐analysis aims to look at the impact of early intravenous Metoprolol in ST‐segment elevation myocardial infarction (STEMI) before percutaneous coronary intervention (PCI) on infarct size, as measured by cardio magnetic resonance (CMR) and left ventricular ejection fraction. Methods We searched the following databases: PubMed, Scopus, Cochrane library, and Web of Science. We included only randomized control trials that reported the use of early intravenous Metoprolol in STEMI before PCI on infarct size, as measured by CMR and left ventricular ejection fraction. RevMan software 5.4 was used for performing the analysis. Results Following a literature search, 340 publications were found. Finally, 18 studies were included for the systematic review, and 8 clinical trials were included in the meta‐analysis after the full‐text screening. At 6 months, the pooled effect revealed a statistically significant association between Metoprolol and increased left ventricular ejection fraction (LVEF) (%) compared to controls (mean difference [MD] = 3.57, [95% confidence interval [CI] = 2.22–4.92], p < .00001), as well as decreased infarcted myocardium(g) compared to controls (MD = −3.84, [95% [CI] = −5.75 to −1.93], p < .0001). At 1 week, the pooled effect revealed a statistically significant association between Metoprolol and increased LVEF (%) compared to controls (MD = 2.98, [95% CI = 1.26−4.69], p = .0007), as well as decreased infarcted myocardium(%) compared to controls (MD = −3.21, [95% CI = −5.24 to −1.18], p = .002). Conclusion A significant decrease in myocardial infarction and increase in LVEF (%) was linked to receiving Metoprolol at 1 week and 6‐month follow‐up.

الإتاحة: https://doi.org/10.1002/clc.23894Test

المؤلفون: Motawea, Karam R., Gaber, Hamed, Singh, Ravi B, Swed, Sarya, Elshenawy, Salem, Talat, Nesreen Elsayed, Elgabrty, Nawal, Shoib, Sheikh, Wahsh, Engy A., Gebril, Sara, Kishk, Mohamed, Elkoumi, Omar A., Attia, Mazen, Khalifa, Ahmed, Habib, Omar Khaled, Foad, Ahmed, Tanas, Yousef, Dean, Yomna E., Hasan, Walaa, Aiash, Hani

المصدر: American Heart Journal ; volume 254, page 250-251 ; ISSN 0002-8703

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

الإتاحة: https://doi.org/10.1016/j.ahj.2022.10.049Test
https://api.elsevier.com/content/article/PII:S0002870322002447?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0002870322002447?httpAccept=text/plainTest